SEC Form 4 · accession 0000874015-18-000055
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Klein III
Director
Period of report
Mar 29, 2018
Accepted (ET)
Mar 30, 2018 · 3:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 29, 2018 | M | 2,000 | $24.42 | A | 11,939 | D | |
| Common StockF1 | Mar 29, 2018 | S | 2,000 | $46.15 | D | 9,939 | D | |
| Common Stock | holding | — | — | — | 100 | I | By son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $24.42 | Mar 29, 2018 | M | 2,000 | A | Jul 1, 2020 | Jun 30, 2026 | Common Stock | 2,000 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 10/11/2017.